Review of NICE Technology Appraisal Guidance No.131; Corticosteroids for the treatment of chronic asthma in children under the age of 12 years, and TA138; Corticosteroids for the treatment of chronic asthma in adults and children aged 12 years and over

Proposal to move guidance to the static list

The scheduled date for review of the above pieces of guidance is November 2012.

This is the date at which the Institute decides whether sufficient new evidence has emerged for the Appraisal Committee to be asked to undertake a full review appraisal.

There is no new evidence to suggest that the recommendations in TA131 and TA138 should change, and there are no ongoing trials that are expected to lead to a change in the recommendations.  Consequently we propose that the original guidance become static.

Topics on the static list may be transferred back to the active list for further appraisal if new evidence becomes available that is likely to have a material effect on the last guidance issued.

In order to be completely confident that this is appropriate, we are asking all relevant consultees and commentators, to inform us of any evidence which would suggest that a review would be beneficial. Please see appendix A for a full list of the organisations we have contacted. 

November 2012